Combination of betulinic acid and chidamide synergistically inhibits Epstein-Barr virus replication through over-generation of reactive oxygen species

Epstein-Barr virus (EBV) has widely infected more than 90% of human populations. Currently, there is no efficient way to remove the virus because the EBV carriers are usually in a latent stage that allows them to escape the immune system and common antiviral drugs. In the effort to develop an effici...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Yu, Haibing, Zhang, Hongyu, Chu, Zhigang, Ruan, Qiongfang, Chen, Xueru, Kong, Danli, Huang, Xiaodong, Li, Huawen, Tang, Huanwen, Wu, Hongjin, Wang, Yifei, Xie, Weiguo, Ding, Yuanling, Yao, Paul
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2017
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5617453/
https://ncbi.nlm.nih.gov/pubmed/28977893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18661
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi